BridgeMD
Compares treatment options for Severe Aortic Stenosis
Official title Comparison of a Single Versus Double Perclose Technique for TAVR
ClinicalTrials.gov ID: NCT06173115
What this study is testing
- What it's testing
- Transcatheter aortic valve replacement (TAVR) has become widely recognized as a minimally invasive approach for aortic valve replacement in patients with severe aortic stenosis. It has been proven to be a safe and effective option for patients who are at low, intermediate, and prohibitive risk for surgical valve replacement.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Patients scheduled to undergo transfemoral TAVR were considered for inclusion in the trial if they met all inclusion and none of the
You likely can't join if
- . Inclusion criteria were an indication for TAVR as judged by the local heart team; selection of the transfemoral access route and a commercially...
- Principal exclusion criteria were a vascular access site anatomy not suitable for percutaneous vascular closure and the occurrence of vascular access...
The study team makes the final eligibility decision.
Where it's taking place
- Bengbu, Anhui, China
- Fuzhou, Fujian, China
- Lanzhou, Gansu, China
- Guangzhou, Guangdong, China
- Zhanjiang, Guangdong, China
- Yulin, Guangxi, China
- Changshacun, Henan, China
- Zhengzhou, Henan, China
- Changsha, Hunan, China
- Shenyang, Liaoning, China
- Jinan, Shandong, China
- Qingdao, Shandong, China
- Xi’an, Shanxi, China
- Chengdu, Sichuan, China
- Ürümqi, Xinjiang, China
- Hangzhou, Zhejiang, China
- Huzhou, Zhejiang, China
- Ningbo, Zhejiang, China
- Wenzhou, Zhejiang, China
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bengbu, Anhui, China; Fuzhou, Fujian, China; Lanzhou, Gansu, China; Guangzhou, Guangdong, China; Zhanjiang, Guangdong, China; Yulin, Guangxi, China and 14 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.